NEUROSCIENTIST: HOW SMOKING CAN BE GOOD FOR YOU | ANDREW HUBERMAN #NEUROSCIENCE #SHORTS

▶️ NICOTINE MAY BE ANTIDOTE TO VACCINE SNAKE VENOM & FLUORIDE METAL POISONING -DR BRYAN ARDIS - Rumble link; https://rumble.com/v47lvbx-dr.-bryan-ardis-nicotine-understanding-the-weapon-and-the-target.html
Pyrazine is a chemical that makes cigarettes Very Addictive, pure nicotine in patches/ gums is not addictive at all. - Cigarette filters are made from paper and fiberglass, when this fiberglass is sucked into the lungs it cuts them, leading into more chemicals transporting in the blood plasma system - Walk into any smoke shop and you'll see signs that say Nicotine may cause cancer, which isn't true.

Death By A Thousand Cuts is the freemasonic Govt cabal motto.

Nicotine Alone Does Not Lead to Addiction: Additives Found in Both Light Cigarettes And E-cigs Harmful https://www.medicaldaily.com/nicotine-alone-does-not-lead-addiction-additives-found-both-light-cigarettes-and-e-337470

Everything that matters have all been lies - I just reverse engineer government lies or flip their lies 180degrees for the path to truth!

Government doesn't want to ban cigarettes for our health, they want to ban cigarettes because they have Nicotine in them which is an antidote to "covid19" filled w/ snake venom and other poisons.
▶️ Ohio State Wexner Medical Center) on YouTube https://www.youtube.com/watch?v=uM7U3aUr6pw

▶️ (COLUMBUS, Ohio) – Nicotine patches were created to help smokers quit, but researchers are conducting a study to see if they can also help patients who suffer from a chronic lung disease. Sarcoidosis is a growth of inflammatory cells, most likely triggered by inhaling pesticides or other toxic materials. If the condition doesn’t go away on its own, it can cause severe lung damage and even death.
Traditionally, sarcoidosis is treated with steroids, but long-term use can cause severe side effects, including high blood pressure, osteoporosis and diabetes.

So, researchers at The Ohio State University Wexner Medical Center conducted a small three-month clinical trial using nicotine patches as a treatment for sarcoidosis. After seeing promising results, they’ve launched a larger randomized trial that will dig deeper into whether nicotine patches can be a long-term solution for managing the disease.

“When we examine the data, we hope to find that the nicotine patches help stop or even reverse the growth of sarcoidosis cells,” said Dr. Elliott Crouser, who is leading the clinical trial. “And because nicotine is a stimulant, patients also get a secondary benefit. Extreme fatigue is the most common symptom of sarcoidosis, and the patches help them get through their day with more energy.”

The trial will last 6 months and researchers will use CAT scans along with a newly developed computer analysis system measure the amount of sarcoidosis in patients’ bodies.

▶️ Ohio State Wexner Medical Center) on YouTube https://www.youtube.com/watch?v=uM7U3aUr6pw
▶️ (COLUMBUS, Ohio) – Nicotine patches were created to help smokers quit, but researchers are conducting a study to see if they can also help patients who suffer from a chronic lung disease. Sarcoidosis is a growth of inflammatory cells, most likely triggered by inhaling pesticides or other toxic materials. If the condition doesn’t go away on its own, it can cause severe lung damage and even death.
Traditionally, sarcoidosis is treated with steroids, but long-term use can cause severe side effects, including high blood pressure, osteoporosis and diabetes.

So, researchers at The Ohio State University Wexner Medical Center conducted a small three-month clinical trial using nicotine patches as a treatment for sarcoidosis. After seeing promising results, they’ve launched a larger randomized trial that will dig deeper into whether nicotine patches can be a long-term solution for managing the disease.

“When we examine the data, we hope to find that the nicotine patches help stop or even reverse the growth of sarcoidosis cells,” said Dr. Elliott Crouser, who is leading the clinical trial. “And because nicotine is a stimulant, patients also get a secondary benefit. Extreme fatigue is the most common symptom of sarcoidosis, and the patches help them get through their day with more energy.”

The trial will last 6 months and researchers will use CAT scans along with a newly developed computer analysis system measure the amount of sarcoidosis in patients’ bodies.